For: | Obed A, Beham A, Püllmann K, Becker H, Schlitt HJ, Lorf T. Patients without hepatocellular carcinoma progression after transarterial chemoembolization benefit from liver transplantation. World J Gastroenterol 2007; 13(5): 761-767 [PMID: 17278200 DOI: 10.3748/wjg.v13.i5.761] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i5/761.htm |
Number | Citing Articles |
1 |
K. V. Menon, A. R. Hakeem, N. D Heaton. Review article: liver transplantation for hepatocellular carcinoma – a critical appraisal of the current worldwide listing criteria. Alimentary Pharmacology & Therapeutics 2014; 40(8): 893 doi: 10.1111/apt.12922
|
2 |
Samer Tohme, Daniel Sukato, Hui-Wei Chen, Nikhil Amesur, Albert B. Zajko, Abhinav Humar, David A. Geller, James W. Marsh, Allan Tsung. Yttrium-90 Radioembolization as a Bridge to Liver Transplantation: A Single-Institution Experience. Journal of Vascular and Interventional Radiology 2013; 24(11): 1632 doi: 10.1016/j.jvir.2013.07.026
|
3 |
Vanessa Villa, Chung Mau Lo. Liver Transplantation for Hepatocellular Carcinoma in Asia. The Oncologist 2007; 12(11): 1321 doi: 10.1634/theoncologist.12-11-1321
|
4 |
|
5 |
Constantine Frangakis, Jean-Francois Geschwind, Daniel Kim, Yong Chen, Ayman Koteish, Kelvin Hong, Eleni Liapi, Christos S. Georgiades. Chemoembolization Decreases Drop-Off Risk of Hepatocellular Carcinoma Patients on the Liver Transplant List. CardioVascular and Interventional Radiology 2011; 34(6): 1254 doi: 10.1007/s00270-010-0077-7
|
6 |
S. Herber, S. Biesterfeld, U. Franz, J. Schneider, J. Thies, M. Schuchmann, C. Düber, M. B. Pitton, G. Otto. Correlation of Multislice CT and Histomorphology in HCC Following TACE: Predictors of Outcome. CardioVascular and Interventional Radiology 2008; 31(4): 768 doi: 10.1007/s00270-007-9270-8
|
7 |
. Experimental and Clinical Transplantation 2018; doi: 10.6002/ect.2018.0017
|
8 |
Giacomo Germani, Kurinchi Gurusamy, Matteo Garcovich, Christian Toso, Giuseppe Fede, Alan Hemming, Kyung-Suk Suh, Achim Weber, Andrew Kenneth Burroughs. Which matters most: Number of tumors, size of the largest tumor, or total tumor volume?. Liver Transplantation 2011; 17(Supplement 2): S58 doi: 10.1002/lt.22336
|
9 |
Hayley C. Oligane, Minzhi Xing, Hyun S. Kim. Effect of Bridging Local-Regional Therapy on Recurrence of Hepatocellular Carcinoma and Survival after Orthotopic Liver Transplantation. Radiology 2017; 282(3): 869 doi: 10.1148/radiol.2016160288
|
10 |
J.M. Kim, C.H.D. Kwon, J.-W. Joh, M.S. Choi, J.H. Lee, K.C. Koh, S.W. Paik, G.S. Kim, S.J. Kim, S.-K. Lee, B.C. Yoo. Effectiveness of Locoregional Therapy Before Living Donor Liver Transplantation in Patients With Hepatocellular Carcinoma Who Meet the Milan Criteria. Transplantation Proceedings 2012; 44(2): 403 doi: 10.1016/j.transproceed.2012.01.067
|
11 |
|
12 |
Hayley C. Oligane, Orrie N. Close, Minzhi Xing, Hyun S. Kim. Bridging locoregional therapy: Longitudinal trends and outcomes in patients with hepatocellular carcinoma. Transplantation Reviews 2017; 31(2): 136 doi: 10.1016/j.trre.2017.01.004
|
13 |
T. Clark Gamblin, Sydney D. Finkelstein, J. Wallis Marsh. Hepatocellular Carcinoma. 2009; : 467 doi: 10.1007/978-1-60327-376-3_18
|
14 |
Antoine Bouchard-Fortier, Réal Lapointe, Pierre Perreault, Louis Bouchard, Gilles Pomier-Layrargues. Transcatheter Arterial Chemoembolization of Hepatocellular Carcinoma as a Bridge to Liver Transplantation: A Retrospective Study. International Journal of Hepatology 2011; 2011: 1 doi: 10.4061/2011/974514
|
15 |
Aiman Obed, Abdalla Bashir, Anwar Jarrad. Rapid Virological Response After Early Treatment with a Combined Therapy of Ledipasvir and Sofosbuvir in HCV Genotype 4 After Living Donor Liver Transplantation in a HCC Downstaged Patient: Case Report and Review of the Literature. American Journal of Case Reports 2016; 17: 672 doi: 10.12659/AJCR.898594
|
16 |
Jason T. Heckman, Michael B. deVera, J. Wallis Marsh, Paulo Fontes, Nikhil B. Amesur, Shane E. Holloway, Michael Nalesnik, David A. Geller, Jennifer L. Steel, T. Clark Gamblin. Bridging Locoregional Therapy for Hepatocellular Carcinoma Prior to Liver Transplantation. Annals of Surgical Oncology 2008; 15(11): 3169 doi: 10.1245/s10434-008-0071-3
|
17 |
Katrin Hoffmann, Ulf Hinz, Norbert Hillebrand, Boris A. Radeleff, Tom M. Ganten, Peter Schirmacher, Jan Schmidt, Markus W. Büchler, Peter Schemmer. Risk factors of survival after liver transplantation for HCC: a multivariate single‐center analysis. Clinical Transplantation 2011; 25(5) doi: 10.1111/j.1399-0012.2011.01465.x
|